TOT BIOPHARM INTERNATIONAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.85 HKD | +6.32% |
|
+17.83% | -6.09% |
| 03-15 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | TOT Biopharm's Loss Narrows in January-September Period | MT |
Chart calendar TOT BIOPHARM International Company Limited
78ff.w61L6930wd8E-LmbEUeBBFh3NUsHE_XCHoJiG2Xtd58.rc4dkYilj7U0p-3xQXezRyIfZQlFe42MSNIxIhzZIfqgxHK9tbCe8nKZ4A~a75fd9ae2fc6efe30dfb21c393e64db9
Upcoming events on TOT BIOPHARM International Company Limited
Past events on TOT BIOPHARM International Company Limited
| 14/03/2024 | Q4 2023 Earnings Release |
| 10/08/2023 | Q2 2023 Earnings Release |
| 27/06/2023 03:00 | Annual General Meeting |
| 22/03/2023 | Q4 2022 Earnings Release |
| 11/08/2022 | Interim 2022 Earnings Release |
| 23/03/2022 | FY 2021 Earnings Release |
| 11/08/2021 | Interim 2021 Earnings Release |
| 25/06/2021 04:00 | Annual General Meeting |
| 22/03/2021 | FY 2020 Earnings Release |
| 12/08/2020 | Interim 2020 Earnings Release |
| 16/03/2020 | FY 2019 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 45,3 58,0 -21.88% | 22,5 53,2 -57.73% | 76,3 51,9 47.06% | 0,00 |
|
EBITDA Million CNY | Released Forecast Spread | -242 -401 39.59% | -257 -215 -19.4% | -225 -202 -11.67% | 0,00 |
|
EBIT Million CNY | Released Forecast Spread | -270 -417 35.35% | -289 -234 -23.22% | -260 -235 -10.7% | 0,00 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million CNY | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -49,9 |
|
EPS CNY | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -0,08 |
| Announcement Date | 17/03/20 | 23/03/21 | 24/03/22 | 23/03/23 |
More events
Past sector events for TOT BIOPHARM International Company Limited
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1875 Stock
- Calendar TOT BIOPHARM International Company Limited
